S 
23.93
+0.04%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥998.3m
FY2016FY2025
Net income
−CN¥18.1m
FY2016FY2025
Free cash flow
−CN¥149.8m
FY2016FY2025
Shareholders' equity
CN¥1.52bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥998.3m | CN¥1.09bn | CN¥954.6m | CN¥868.2m | CN¥746.9m | CN¥571.7m | CN¥583.6m | CN¥541.1m | CN¥471.2m | CN¥411.6m |
| Research and development | CN¥39.5m | CN¥36.5m | CN¥31.1m | CN¥31.2m | CN¥32.3m | CN¥22.1m | CN¥21.6m | CN¥21.5m | CN¥17.4m | CN¥12.2m |
| Operating income | −CN¥25.8m | CN¥127.4m | CN¥103.8m | CN¥107.1m | CN¥130.0m | CN¥101.7m | CN¥91.1m | CN¥84.7m | CN¥81.7m | CN¥69.5m |
| Net income | −CN¥18.1m | CN¥110.8m | CN¥89.5m | CN¥93.3m | CN¥112.4m | CN¥86.8m | CN¥76.7m | CN¥72.9m | CN¥69.6m | CN¥61.5m |
| Diluted earnings per share | -0.23 | 0.91 | 0.71 | 0.75 | 0.89 | 1.69 | 0.81 | 0.92 | 0.87 | 0.77 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥1.82bn | CN¥1.86bn | CN¥1.77bn | CN¥1.72bn | CN¥1.60bn | CN¥1.49bn | CN¥420.4m | CN¥355.9m | CN¥371.1m | CN¥307.0m |
| Cash and short-term investments | — | CN¥963.1m | CN¥1.08bn | CN¥1.25bn | CN¥1.24bn | CN¥1.23bn | CN¥172.8m | CN¥146.8m | CN¥178.5m | CN¥141.9m |
| Total liabilities | CN¥300.4m | CN¥312.3m | CN¥264.1m | CN¥269.0m | CN¥202.8m | CN¥168.0m | CN¥151.0m | CN¥147.4m | CN¥184.6m | CN¥162.3m |
| Debt | — | CN¥53.8m | CN¥55.5m | CN¥60.1m | CN¥18.4m | CN¥15.0m | CN¥252,278 | CN¥10.3m | CN¥15.4m | CN¥10.0m |
| Shareholders' equity | CN¥1.52bn | CN¥1.55bn | CN¥1.51bn | CN¥1.45bn | CN¥1.40bn | CN¥1.32bn | CN¥269.4m | CN¥208.5m | CN¥186.4m | CN¥144.7m |
| Shares outstanding | 80m | 122m | 126m | 125m | 126m | 51m | 95m | 80m | 80m | 80m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥3.8m | CN¥172.3m | CN¥120.9m | CN¥55.5m | CN¥57.1m | CN¥79.1m | CN¥96.1m | CN¥41.6m | CN¥92.6m | CN¥98.1m |
| Capital spending | −CN¥153.7m | −CN¥220.8m | −CN¥214.6m | −CN¥37.8m | −CN¥27.5m | −CN¥19.9m | −CN¥44.2m | −CN¥21.9m | −CN¥29.3m | −CN¥12.7m |
| Free cash flow | −CN¥149.8m | −CN¥48.5m | −CN¥93.7m | CN¥17.6m | CN¥29.6m | CN¥59.3m | CN¥51.8m | CN¥19.8m | CN¥63.4m | CN¥85.3m |
| Dividends paid | −CN¥35.4m | −CN¥36.2m | −CN¥37.0m | −CN¥36.0m | −CN¥36.0m | −CN¥508,321 | −CN¥15.8m | −CN¥49.8m | −CN¥30.4m | −CN¥1.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥252.2m | CN¥271.5m | CN¥267.5m | CN¥219.2m | CN¥271.5m | CN¥240.1m | CN¥321.2m | CN¥247.5m |
| Operating income | −CN¥3.2m | CN¥23.1m | CN¥431,144 | −CN¥22.0m | −CN¥4.3m | CN¥8.0m | CN¥28.1m | CN¥19.7m |
| Net income | −CN¥6.0m | CN¥18.4m | −CN¥2.6m | −CN¥18.7m | −CN¥4.1m | CN¥7.2m | CN¥23.3m | CN¥18.2m |
| Diluted earnings per share | -0.08 | 0.23 | -0.03 | -0.23 | -0.05 | 0.09 | 0.19 | 0.15 |
| Cash from operations | — | — | — | −CN¥4.0m | −CN¥15.0m | −CN¥37.0m | — | CN¥35.0m |
| Capital spending | −CN¥82.0m | −CN¥47.0m | −CN¥94.0m | −CN¥18.0m | −CN¥19.0m | −CN¥21.0m | −CN¥83.0m | −CN¥68.0m |
| Free cash flow | — | — | — | −CN¥22.0m | −CN¥34.0m | −CN¥58.0m | — | −CN¥33.0m |
| Total assets | CN¥1.73bn | CN¥1.81bn | CN¥1.82bn | CN¥1.78bn | CN¥1.83bn | CN¥1.85bn | CN¥1.86bn | CN¥1.73bn |
| Cash and short-term investments | — | — | — | CN¥801.9m | CN¥826.7m | CN¥901.3m | CN¥963.1m | CN¥904.3m |
| Debt | — | — | — | CN¥2.2m | CN¥11.0m | CN¥10.0m | CN¥10.0m | CN¥10.0m |
| Shareholders' equity | CN¥1.49bn | CN¥1.54bn | CN¥1.52bn | CN¥1.54bn | CN¥1.56bn | CN¥1.56bn | CN¥1.55bn | CN¥1.53bn |
Financial ratios
Data as of 23 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Operating margin | -2.3% | 11.9% | 10.8% | 12.4% | 17.5% | 17.8% | — |
| Net margin | -1.8% | 10.2% | 9.4% | 10.7% | 15.1% | 15.2% | — |
| Return on equity | -1.2% | 7.1% | 5.9% | 6.4% | 8.1% | 6.6% | — |
| Return on assets | -1.0% | 5.9% | 5.1% | 5.4% | 7.0% | 5.8% | — |
| Free cash flow yield | 8.6% | 14.0% | 11.5% | 3.2% | 2.9% | 8.4% | — |
| Revenue growth | -8.2% | 13.9% | 10.0% | 16.2% | 30.7% | -2.0% | — |
| Earnings growth | -116.4% | 23.8% | -4.1% | -17.0% | 29.5% | 13.2% | — |
| Current ratio | 4.84x | 5.51x | 6.03x | 6.84x | 7.24x | 8.18x | — |
| Debt to equity | — | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x |
| Equity ratio | 83.4% | 83.2% | 85.1% | 84.4% | 87.3% | 88.7% | — |
| Interest coverage | -9.69x | 46.04x | 36.68x | 138.31x | 147.78x | 158.56x | — |
| R&D as a share of sales | 4.0% | 3.4% | 3.3% | 3.6% | 4.3% | 3.9% | — |
| Buybacks as a share of market value | 34.7% | 3.2% | -0.8% | 1.0% | -145.9% | 46.0% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 4.8% | 11.8% | 11.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 4.9% | 8.0% | 10.4% | 11.8% |
| Net margin | 4.4% | 7.0% | 9.1% | 10.2% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | -104.3 | 25.3 | 33.0 | 40.0 | 45.9 | 22.7 |
| Price to sales | 1.9 | 2.6 | 3.1 | 4.3 | 6.9 | 3.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 5 years. Last went ex-dividend on 2 Jun 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Paid in the year | 0.40 | 0.286 | 0.286 | 0.286 | 0.286 | 0.286 |
- 7-for-5 split · 27 May 2025
- 3-for-2 split · 1 Jun 2021
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.